Cargando…
Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes
Type 1 diabetes (T1D) is an organ-specific disease characterized by the deficiency of insulin caused by the autoimmune destruction of pancreatic islet β cells. Stem cell-based therapies play essential roles in immunomodulation and tissue regeneration, both of which hold great promise for treating ma...
Autores principales: | Hu, Wei, Song, Xiang, Yu, Haibo, Sun, Jingyu, Wang, Hongjun, Zhao, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789747/ https://www.ncbi.nlm.nih.gov/pubmed/35095751 http://dx.doi.org/10.3389/fendo.2021.682145 |
Ejemplares similares
-
Therapeutic Potentials of Extracellular Vesicles for the Treatment of Diabetes and Diabetic Complications
por: Hu, Wei, et al.
Publicado: (2020) -
Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
por: Liu, Jie, et al.
Publicado: (2021) -
The role of adipose-derived stem cells-derived extracellular vesicles in the treatment of diabetic foot ulcer: Trends and prospects
por: Deng, Hongyan, et al.
Publicado: (2022) -
An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease
por: Lin, Yongda, et al.
Publicado: (2022) -
Extracellular Vesicles from Adipose Tissue—A Potential Role in Obesity and Type 2 Diabetes?
por: Gao, Xuan, et al.
Publicado: (2017)